BRMS1 downregulation alters the tumor microenvironment and induces immunotherapy resistance in lung adenocarcinoma

被引：0
|
作者：
Lankadasari, Manendra B.
Liu, Yuan
Mastrogiacomo, Brooke
Zhu, Yingjie
Dunne, Elizabeth G.
Fick, Cameron N.
Harsha, Choudhary
Reis-Filho, Jorge S.
Jones, David R.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-6596
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6596
引用
收藏
页数：2
相关论文
共 50 条
  • [1] BRMS1 alters the tumor inflammatory signature and immune infiltration in lung adenocarcinoma
    Lankadasari, Manendra B.
    Liu, Yuan
    He, Di
    Bapat, Samhita
    Mastrogiacomo, Brooke
    Lengel, Harry B.
    Jones, David R.
    CANCER RESEARCH, 2022, 82 (12)
  • [2] BRMS1 expression in resected lung adenocarcinoma
    Galetta, Domenico
    Pizzutilo, Pamela
    Longo, Vito
    TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 : S364 - S366
  • [3] Decrease in Expression of BRMS1 Correlates with the Tumor Progression and Metastatic Potential of Colorectal Adenocarcinoma
    Phadke, P. A.
    Ashby-Richardson, H.
    Barry, A. Shepard
    Naber, S. P.
    Welch, D. R.
    MODERN PATHOLOGY, 2009, 22 : 145A - 146A
  • [4] Decrease in Expression of BRMS1 Correlates with the Tumor Progression and Metastatic Potential of Colorectal Adenocarcinoma
    Phadke, P. A.
    Ashby-Richardson, H.
    Barry, A. Shepard
    Naber, S. P.
    Welch, D. R.
    LABORATORY INVESTIGATION, 2009, 89 : 145A - 146A
  • [5] BRMS1 Expression in Surgically Resected Lung Adenocarcinoma Predicts Future Metastases and Is Associated with a Poor Prognosis
    Bucciarelli, Peter R.
    Tan, Kay See
    Chudgar, Neel P.
    Brandt, Whitney
    Montecalvo, Joseph
    Eguchi, Takashi
    Liu, Yuan
    Aly, Rania
    Travis, William D.
    Adusumilli, Prasad S.
    Jones, David R.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (01) : 73 - 84
  • [6] BRMS1 downregulation is a poor prognostic biomarker in anaplastic thyroid carcinoma patients
    Wu, Yu
    Wang, Huijuan
    Zhi, Jingtai
    Hu, Linfei
    Hou, Xiukun
    Ruan, Xianhui
    Zheng, Xiangqian
    Liu, Hui
    Gao, Ming
    ONCOTARGETS AND THERAPY, 2019, 12 : 6937 - 6945
  • [7] AGRN-Positive Tumor Cells Promoting Immunotherapy Resistance in Lung Adenocarcinoma by Reshaping the Immune Microenvironment
    Zhang, H.
    Leng, X.
    Han, Y.
    Li, J.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S82 - S82
  • [8] JAG1 is correlated to suppressive immune microenvironment and predicts immunotherapy resistance in lung adenocarcinoma
    He, Jing
    Li, Lu
    Lv, Lulu
    Chen, Xiaoyan
    Ge, Minghui
    Ren, Yong
    Tang, Xinyu
    Liu, Ping
    Gao, Wen
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [9] Molecular characterization based on tumor microenvironment-related signatures for guiding immunotherapy and therapeutic resistance in lung adenocarcinoma
    Jie, Yamin
    Wu, Jianing
    An, Dongxue
    Li, Man
    He, Hongjiang
    Wang, Duo
    Gu, Anxin
    Mingyan, E.
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [10] A germline SNP in BRMS1 predisposes patients with lung adenocarcinoma to metastasis and can be ameliorated by targeting c-fos
    Liu, Yuan
    Chudgar, Neel
    Mastrogiacomo, Brooke
    He, Di
    Lankadasari, Manendra B.
    Bapat, Samhita
    Jones, Gregory D.
    Sanchez-Vega, Francisco
    Tan, Kay See
    Schultz, Nikolaus
    Mukherjee, Semanti
    Offit, Kenneth
    Bao, Yongde
    Bott, Matthew J.
    Rekhtman, Natasha
    Adusumilli, Prasad S.
    Li, Bob T.
    Mayo, Marty W.
    Jones, David R.
    SCIENCE TRANSLATIONAL MEDICINE, 2022, 14 (665)
12345